Search clinical trials for: 177Lu-RAD204

Total 297 results

Radiopharm Theranostics, Ltd

Recruiting

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Non Small Cell Lung Cancer | Endometrial Cancer | TNBC, Triple Negative Breast Cancer | Cutaneous Melanoma | HNSCC | Mmr Deficiency | MSI-High | PDL1 Gene Mutation | Small Cell Lung Cancer ( SCLC )

Australia
Radiopharm Theranostics, Ltd

Recruiting

HEAT Trial (HER2 Antibody Therapy With Lutetium-177) (RAD202)

Advanced Solid Tumors | HER2 Gene Mutation

Australia
Ipsen

Terminated

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Gastric Cancer | Colorectal Cancer | Bone Cancer | Squamous Cell Carcinoma of the Head and Neck | Advanced Cancer | Recurrent Disease | Pancreatic Ductal Adenocarcinoma | Metastatic Tumours

United States, France, Belgium, Switzerland, Netherlands
The First Affiliated Hospital of Xiamen University

Completed

Evaluation of 177Lu-TATE-EB-01（LNC1010）in SSTR2-positive Tumors

SSTR2-positive Tumors

China
Telix Pharmaceuticals (Innovations) Pty Limited
Medpace, Inc.

Recruiting

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC (LUTEON)

Renal Cell Carcinoma (RCC) | Renal Cell Cancer Metastatic | ccRCC | Renal Cell Cancer, Recurrent | Clear Cell Renal Cell Cancer (ccRCC) | Renal Cell Carcinoma (Kidney Cancer)

Australia

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe